Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealthnews2024-01-05T21:20:53+00:00January 5th, 2024|The New York Times|
Can Ozempic and Weight Loss Drugs Treat Other Diseases?news2023-12-20T16:09:05+00:00December 20th, 2023|The New York Times|
Thanksgiving Is All About Food. Will Ozempic Make It Better or Worse?news2023-11-19T10:00:33+00:00November 19th, 2023|The New York Times|
Zepbound, el nuevo medicamento aprobado por la FDA para perder pesonews2023-11-13T10:01:53+00:00November 13th, 2023|The New York Times|
Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Showsnews2023-11-12T05:20:43+00:00November 12th, 2023|The New York Times|
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovynews2023-11-09T01:02:09+00:00November 9th, 2023|The New York Times|
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.news2023-11-08T18:34:20+00:00November 8th, 2023|The New York Times|
The Wegovy Shortage Drags On, Leaving Patients in Limbonews2023-10-05T09:00:15+00:00October 5th, 2023|The New York Times|
Does Ozempic Stop Working Over Time? Why Weight Loss Can Plateaunews2023-09-19T08:29:26+00:00September 19th, 2023|The New York Times|
What Obesity Drugs and Antidepressants Have in Commonnews2023-09-10T16:31:10+00:00September 10th, 2023|The New York Times|